IL165525A0 - Intermediates and a process for the manufacturing for antihypertensive dihydropyridine derivative suitable for pharmaceutical compositions - Google Patents

Intermediates and a process for the manufacturing for antihypertensive dihydropyridine derivative suitable for pharmaceutical compositions

Info

Publication number
IL165525A0
IL165525A0 IL16552504A IL16552504A IL165525A0 IL 165525 A0 IL165525 A0 IL 165525A0 IL 16552504 A IL16552504 A IL 16552504A IL 16552504 A IL16552504 A IL 16552504A IL 165525 A0 IL165525 A0 IL 165525A0
Authority
IL
Israel
Prior art keywords
intermediates
manufacturing
pharmaceutical compositions
dihydropyridine derivative
derivative suitable
Prior art date
Application number
IL16552504A
Original Assignee
Motivan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Motivan Ltd filed Critical Motivan Ltd
Priority to IL16552504A priority Critical patent/IL165525A0/en
Priority to PCT/IL2005/001290 priority patent/WO2006059332A1/en
Priority to EP05812950A priority patent/EP1824824A1/en
Publication of IL165525A0 publication Critical patent/IL165525A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
IL16552504A 2004-12-02 2004-12-02 Intermediates and a process for the manufacturing for antihypertensive dihydropyridine derivative suitable for pharmaceutical compositions IL165525A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IL16552504A IL165525A0 (en) 2004-12-02 2004-12-02 Intermediates and a process for the manufacturing for antihypertensive dihydropyridine derivative suitable for pharmaceutical compositions
PCT/IL2005/001290 WO2006059332A1 (en) 2004-12-02 2005-12-01 Intermediates for the preparation of lercanidipine
EP05812950A EP1824824A1 (en) 2004-12-02 2005-12-01 Intermediates for the preparation of lercanidipine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL16552504A IL165525A0 (en) 2004-12-02 2004-12-02 Intermediates and a process for the manufacturing for antihypertensive dihydropyridine derivative suitable for pharmaceutical compositions

Publications (1)

Publication Number Publication Date
IL165525A0 true IL165525A0 (en) 2006-01-15

Family

ID=35945255

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16552504A IL165525A0 (en) 2004-12-02 2004-12-02 Intermediates and a process for the manufacturing for antihypertensive dihydropyridine derivative suitable for pharmaceutical compositions

Country Status (3)

Country Link
EP (1) EP1824824A1 (en)
IL (1) IL165525A0 (en)
WO (1) WO2006059332A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080048065A (en) * 2005-09-16 2008-05-30 그렌마크 파머수티칼스 엘티디. Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof
CN102020602B (en) * 2009-09-18 2013-12-25 深圳信立泰药业股份有限公司 Crystal form of lercanidipine hydrochloride and preparation method thereof and crystal form-containing medicinal composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8403866D0 (en) * 1984-02-14 1984-03-21 Recordati Chem Pharm Diphenylalkylaminoalkyl esters
US5912351A (en) * 1995-05-12 1999-06-15 Recordati, S.A. Chemical And Pharmaceutical Company Anhydrous 1,4-Dihydropyridines and salts thereof

Also Published As

Publication number Publication date
WO2006059332A1 (en) 2006-06-08
EP1824824A1 (en) 2007-08-29

Similar Documents

Publication Publication Date Title
EP1741703A4 (en) Pyridone derivative
GB0219896D0 (en) Dihydropyridine derivatives
ZA200606229B (en) A pharmaceutical composition
IL175860A0 (en) Method for the production of a solid, orally applicable pharmaceutical composition
IL175973A0 (en) Pharmaceutical compositions comprising lercanidipine
EP1951686A4 (en) Quinazoline derivatives as a multiplex inhibitor and method for the preparation thereof
IL228730A (en) Pharmaceutical manufacturing process
EP1820797A4 (en) Substituted pyridone derivative
ZA200702418B (en) Taste-masking Pharmaceutical compositions
ZA200700685B (en) Novel piperidine derivative for the treatment of depression
LT1729739T (en) Process for preparing a solid pharmaceutical composition
EP1809613A4 (en) Methods of making 2,6-diaryl piperidine derivatives
IL182703A (en) Pharmaceutical compositions comprising a camptothecin derivative
IL180893A (en) Method for the preparation of a d-erythro-2,2-difluoro-2-deoxy-1-oxoribose derivative
IL182505A0 (en) Purified phospholipid-non-steroidal, anti-inflammatory drug associated compositions and method for preparing and using same
GB0405033D0 (en) Novel pharmaceutical compositions
GB0406378D0 (en) Novel pharmaceutical compositions
EP1805154A4 (en) Pharmaceutical compositions
HK1108580A1 (en) A process for the preparation of [1,4,5]-oxadiazepine derivatives
IL186862A0 (en) Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives
IL182955A0 (en) Pharmaceutical compositions comprising a benzothiazol derivative and their use
HK1100424A1 (en) Oral preparations and process for production thereof
IL181938A0 (en) Lercanidipine capsules
EP1736474A4 (en) Piperidine derivative
GB0400452D0 (en) A pharmaceutical composition